SCHEMBL23747674

SCHEMBL23747674

COc1ccc(CNC(=O)Nc2ccc(CN3CC[C@@H](C)CC3=O)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.56
NPC1 O15118 4/20 0.54
RAB9A P51151 4/20 0.54
HDAC1 Q13547 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
MAPT P10636 3/20 0.50
HTT P42858 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
POLB P06746 1/20 0.49
CCR3 P51677 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
MAPK1 P28482 1/20 0.48
ROCK2 O75116 1/20 0.48
NAMPT P43490 2/20 0.47
MCHR1 Q99705 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23747457 1.00 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747671 1.00 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747672 0.89 CHRM1 (0.57) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL23747670 0.89 CHRM1 (0.57) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL23747395 0.89 CHRM1 (0.57) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL23747337 0.86 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747483 0.86 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747479 0.86 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747321 0.84 SMN1; SMN2 (0.63) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747345 0.84 SMN1; SMN2 (0.66) SMN1; SMN2NPC1RAB9AHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
WO-2021159015-A1 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 SMN1; SMN2 1161/4885NPC1 463/4885RAB9A 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.